Skip to content

Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Software, in the Care and Support of Elderly People Living in Nursing Homes

Clinical Investigation Evaluating the Use of NETSmart Solution , Incorporated to NETSoins Software, in the Care and Support of Elderly People Living in Nursing Homes

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07027358
Acronym
NETSMART DM
Enrollment
30
Registered
2025-06-18
Start date
2024-09-03
Completion date
2025-04-01
Last updated
2025-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug Interaction, Fall Prevention, Pressure Injury, Undernutrition

Brief summary

NETSmart software is designed to help doctors, nurses and care assistants adapt the care of elderly people living in nursing homes to the following risks: * pressure injuries * undernutrition * interactions between different drugs * falls. The software analyzes the information in your medical records, alerts your medical team to any points of vigilance, and suggests appropriate recommendations. The study comprises 2 distinct phases: * An initial 4-month phase, during which the medical staff will simply assess whether the NETSmart software's recommendations are relevant, without changing their current practice, i.e. they will continue to care for you as usual; * A second 6-month phase, during which your caregivers will follow the software's recommendations if they feel they are relevant, and potentially adapt your care.

Interventions

DEVICENETSmart software

Use of NETSmart software by healthcare professionals

Sponsors

RCTs
CollaboratorINDUSTRY
Teranga Software
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female, at least 70 years old * Permanent resident at an investigation site for at least 6 months. * Considered an at-risk patient, i.e. meeting at least one of the following criteria : * Braden score \< 16 * At risk of pressure ulcer according to the investigator's judgment * At risk of undernutrition as judged by the investigator * Undergoing at least 6 drug treatments * At risk of falls as judged by the investigator * Affiliated with the French social security system * Having given informed, dated and signed consent to participate in the investigation

Exclusion criteria

* Patient with a life expectancy of less than 2 months as judged by the investigator * Patient who is participating or has participated in another investigation or study involving the use of a medical device or drug within 30 days prior to inclusion

Design outcomes

Primary

MeasureTime frameDescription
Percentage of clinically relevant recommandations provided by NETSmart4 monthsNETSmart Software provides recommendations to the healthcare professionals. The healthcare professionals are able to mention in the software whether the recommandations are clinically relevant or not. Data will be extracted from the software to analyze this primary outcome.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026